YI

111, Inc.

111, Inc. (YI) has 11 SEC Form 4 filings (58 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 16, 2026.

The most active filer is Director Sun Jian David with 6 filings. Insiders have net sold $141K over the trailing 6 months.

  • Industry:Medical - Pharmaceuticals
  • CEO:Junling Liu
  • Employees:1,238
  • HQ:Shanghai, CN
  • IPO:2018-09-12

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$141K

reported sales (SEC code S)

Unique Insiders

3

in the rolling window

Market Cap

$659.6M

latest known value

Source
Sale$389Jun 16SEC ↗
Sale$850Jun 16SEC ↗
Sale$11KJun 16SEC ↗
Sale$10KJun 16SEC ↗
Sale$8KJun 16SEC ↗
Sale$18KJun 16SEC ↗
Sale$3KJun 16SEC ↗
Sale$25KJun 16SEC ↗
Sale$26KJun 16SEC ↗
Sale$14KJun 16SEC ↗
Luo Jun JustinFirst filing
Sale$8KMay 29SEC ↗
Luo Jun JustinFirst filing
Sale$18KMay 29SEC ↗

Related companies

111, Inc. is in the Healthcare sector.